Advertisement

The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis

Published:January 07, 2009DOI:https://doi.org/10.1016/j.ejca.2008.11.003

      Abstract

      This paper describes the collection, standardisation and checking of cancer survival data included in the EUROCARE-4 database. Methods for estimating relative survival are also described. Incidence and vital status data on newly diagnosed European cancer cases were received from 93 cancer registries in 23 countries, covering 151,400,000 people (35% of the participating country population). The third revision of the International Classification of Diseases for Oncology was used to specify tumour topography and morphology. Records were extensively checked for consistency and compatibility using multiple routines; flagged records were sent back for correction. An algorithm assigned standardised sequence numbers to multiple cancers. Only first malignant cancers were used to estimate relative survival from registry, year, sex and age-specific life tables. Age-adjusted and Europe-wide survival were also estimated.
      The database contains 13,814,573 cases diagnosed in 1978–2002; 92% malignant. A negligible proportion of records was excluded for major errors. Of 5,753,934 malignant adult cases diagnosed in 1995–2002, 5.3% were second or later cancers, 2.7% were known from death certificates only and 0.4% were discovered at autopsy. The remaining 5,278,670 cases entered the survival analyses, 90% of these had microscopic confirmation and 1.3% were censored alive after less than five years’ follow-up. These indicators suggest satisfactory data quality that has improved since EUROCARE-3.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Berrino F, Sant M, Verdecchia A, et al., editors. Survival of cancer patients in Europe: the EUROCARE study. IARC Scientific Publications No. 132. Lyon, France: International Agency for Research on Cancer; 1995.

      2. Berrino F, Capocaccia R, Esteve J, et al., editors. Survival of cancer patients in Europe: the EUROCARE-2 study. IARC Scientific Publications No. 151. Lyon, France; International Agency for Research on Cancer; 1999.

      3. Berrino F, Capocaccia R, Coleman MP, et al., editors. Survival of cancer patients in Europe: the EUROCARE-3 study. Ann Oncol, 2003;14(Suppl. 5).

        • Gatta G.
        • Ciccolallo L.
        • Kunkler I.
        • et al.
        Survival from rare cancer in adults: a population-based study.
        Lancet Oncol. 2006; 7: 132-140
        • Fritz A.
        • Percy C.
        • Jack A.
        • et al.
        WHO international classification of diseases for oncology.
        3rd ed. WHO, Geneva2000
        • Berrino F.
        • De Angelis R.
        • Sant M.
        • et al.
        Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–1999.
        Lancet Oncol. 2007; 8: 773-783
        • Verdecchia A.
        • Francisci S.
        • Brenner H.
        • et al.
        Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data.
        Lancet Oncol. 2007; 8: 784-796
        • Sant M.
        • Allemani C.
        • Santaquilani M.
        • et al.
        • the EUROCARE Working Group
        EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary.
        Eur J Cancer. 2009; 45: 931-991
        • Brenner H.
        • Francisci S.
        • De Angelis R.
        • et al.
        • the EUROCARE Working Group
        Long-term survival expectations of cancer patients in Europe in 2000–2002.
        Eur J Cancer. 2009; 45: 1028-1041
      4. EUROCARE study web-site: <http://www.eurocare.it/> [accessed 03.06.08].

      5. Ferlay J, Burkhard C, Whelan S, Parkin DM. Check and conversion programs for Cancer Registries. International Agency for Research on Cancer, Technical Report No. 42: Lyon (France); 2005. <http://www.iacr.com.fr/TR42.htm>.

        • Rosso S.
        • De Angelis R.
        • Ciccolallo L.
        • et al.
        • the EUROCARE Working Group
        Multiple tumours in survival estimates.
        Eur J Cancer. 2009; 45: 1080-1094
      6. Surveillance Research Program, National Cancer Institute. SEER site recode <http://seer.cancer.gov/siterecode/icdo3_d01272003/> [accessed 18.07.08].

      7. Ries LAG, Melbert D, Krapcho M. et al. SEER cancer statistics review, 1975–2005. National Cancer Institute: Bethesda MD; 2008. <http://seer.cancer.gov/csr/1975_2005>.

        • Gatta G.
        • Zigon G.
        • Capocaccia R.
        • et al.
        • the EUROCARE Working Group
        Survival of European children and young adults with cancer diagnosed 1995–2002.
        Eur J Cancer. 2009; 45: 992-1005
        • Capocaccia R.
        • Gatta G.
        • Roazzi P.
        • et al.
        The EUROCARE-3 database: methodology of data collection, standardization, quality control and statistical analysis.
        Ann Oncol. 2003; 14: v14-v27
        • Navarro C.
        The National Death Index: a largely expected advance in the access to mortality data.
        Gac Sanit. 2006; 20: 421-423
        • Brenner H.
        • Söderman B.
        • Hakulinen T.
        Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland.
        Int J Epidemiol. 2002; 31: 456-462
      8. Surveillance Research Program, National Cancer Institute SEER∗Stat software. Version 6.4.4; 2008. <www.seer.cancer.gov/seerstat>.

        • Hakulinen T.
        Cancer survival corrected for heterogeneity in patient withdrawal.
        Biometrics. 1982; 38: 933-942
        • Micheli A.
        • Baili P.
        • Quinn M.
        • et al.
        Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas.
        Ann Oncol. 2003; 14: 28-40
        • Baili P.
        • Micheli A.
        • Montanari A.
        • Capocaccia R.
        Comparison of four methods for estimating complete life tables from abridged life tables using mortality data supplied to EUROCARE-3.
        Math Populat Stud. 2005; 12: 183-198
        • Elandt-Johnson R.C.
        • Johnson N.L.
        Survival models and data analysis. Wiley Series in Probability and Mathematical Statistics. John Wiley & Sons, Inc., Indianapolis1980
        • Corazziari I.
        • Quinn M.
        • Capocaccia R.
        Standard cancer patients population for age standardizing survival ratios.
        Eur J Cancer. 2004; 40: 2307-2316
        • Bossard N.
        • Velten M.
        • Remontet L.
        • et al.
        Survival of cancer patients in France: A population-based study from The Association of the French Cancer Registries (FRANCIM).
        Eur J Cancer. 2007; 43: 149-160
        • Gondos A.
        • Bray F.
        • Brewster D.H.
        • et al.
        Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries.
        Eur J Cancer. 2008; 44: 1463-1475
      9. Cancer in Germany 2003–2004: incidence and trends, 6th ed. Published jointly by the Robert Koch Institute and the Association of Population-based Cancer Registries in Germany; 2008. <http://www.gekid.de/> [accessed 29.09.08].

      10. Swerdlow S.H. Campo E. Harris N.L. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. International Agency for Research on Cancer, Lyon, France2008
        • Robinson D.
        • Sankila R.
        • Hakulinen T.
        • Møller H.
        Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates.
        Eur J Cancer. 2007; 43: 903-913